Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.
Quick Stats
Jan 30, 202641.8
AI Score
HOLD0.01
Volume Ratio
Mar 03, 2026
Next Earnings
11
+ve Days (30d)
17
-ve Days (30d)
CYCN Stock Summary
Last updated Jan 30, 2026
CYCN is currently trading at $1.36, positioned below its 200-day moving average of $2.39, suggesting bearish momentum. The stock has a 52-week range of $1.16 to $6.25.
Technical Analysis: The 50-day moving average stands at $1.5, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 43.713, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.489, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates CYCN at 41.8/100 with a HOLD recommendation.
CYCN (Cyclerion Therapeutics, Inc. Common Stock) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 43.713 |
| CMF (20) | -0.489 |
| ROC (10) | 1.838 |
| ADX (14) | 19.415 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.036 |
| AROONOSC (14) | -50.0 |
| WILLAMS %R (14) | -94.231 |
| MFI (14) | 48.418 |
CYCN Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
CYCN Price vs Max Options Open Interest
CYCN Max Change In Options Open Interest
CYCN Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CYCN Daily Out of Money Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CYCN Daily In the Money Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CYCN Most Active Options by Volume(near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Cyclerion Therapeutics, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
CYCN Moving Averages Analysis
CYCN (Cyclerion Therapeutics, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 1.42 |
| 20 | 1.52 |
| 30 | 1.47 |
| 50 | 1.5 |
| 100 | 1.85 |
| 200 | 2.39 |
CYCN Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 5.2 million |
| Earnings/Share ($) | -0.7 |
| Net Proft Margin (%) | -0.7702 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 0 |
| EPS Estimate Next Year ($) | 0 |
| WallStreet Target Price ($) | 4 |
| Most Recent Quarter |